InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by See Tai Sandi. Director active across 1 company, notably Lexeo Therapeutics, Inc.. Aggregated, 7 reports have been recorded. Split: 0 buy · 4 sells. Total volume traded: €12k. History available since 7 January 2025. The latest transaction was disclosed on 18 November 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
See Tai Sandi is a declarant linked to Lexeo Therapeutics, Inc., where the listed role is Chief Development Officer. The record shows 7 filings in total, and across the recent sampled filings dated from 2025-01-10 to 2025-11-20, sell transactions total 11801 EUR and the most frequent transaction nature is Cession.